1.              “High-Value Hi-Tech Product Introduction in Emerging Countries: The Role and Construction of Legitimacy”, with Ajay Thutupalli and Eduardo Urias, Qualitative Market Research, 20, 2, 208-225, 1(2017).(pdf)

2.              “On diarrhoea in adolescents and school toilets: Insights from an Indian village school study” with Timothée Frühauf and Arijita Dutta, forthcoming in Journal of Development Studies.  

3.              “Catalysing Innovation for Social Impact: The Role of Social Enterprises in the Indian Sanitation Sector” with Shuan SadreGhazi and Suraksha Gupta, in Technological Forecasting and Social Change, 121, 216-227, (2017). (pdf)  

4.              “On incidence of diarrhoea among children in India: Can the Gordian knot of complementarities be cut?” with Arijita Dutta and Gitanjali Hajra, Economic and Political Weekly Vol. 51, Issue No. 22, 28 May, 121-129 (2016).(pdf)  

5.              “Emergence of Controversy in Technology Transitions: Green Revolution and Bt cotton in India”, with Ajay Thutupalli Technological Forecasting and Social Change, 100, 198–212 (2015). (pdf)

6.              “Women entrepreneurs in the informal economy: Is formalization the only solution for business sustainability?" with A.Thutupalli,T.Medovarszki,S.Chattopadhyay,V.Ravichandran, Chapter 23 In Routeledge Handbook of Entrepreneurship in Developing countries, 2016, Edited by Colin C. Williams and Anjula Gurtoo. (pdf)

7.              “Access to Critical Medicines: When are compulsory licenses effective in price negotiations?” with Eduardo Urias, Social Science & Medicine, 135, 75-83 (2015). (pdf)

8.              “Can breakthrough innovations serve the poor (bop) and create reputational (CSR) value? Indian case studies” with Mukherjee V.,Technovation 34, 295-304 (2014). (pdf)

9.              “On the Diffusion of Toilets as Bottom of Pyramid Innovation: Lessons from Sanitation Entrepreneurs” with S. SadreGhazi and G. Duysters, Technological forecasting and social change. 79, 676–687, (2012).(pdf)  

10.              “Playing in Invisible Markets: The Market for toilets and empowerment”, The Charles Cooper Annual Memorial Lecture, UNU-Merit working paper, #2008-012, 676–687, (2008).(pdf)  

11.              “Economic Development in India: A Brief Outline of Theory, Policy and Progress -A personal view”  eSS Occasional Papers, Vol 1, No. 1, May-July 2008, 1-12.(pdf)  

12.              “Commercializing an Innovation in an Invisible Market: Case of Ecosan toilets” with A.Benycar and A. Didier eSS Occasional Papers, Vol.1, No.1, May-July 2008, 77-90.(pdf)

1.              “Emergence of Controversy in Technology Transitions: Green Revolution and Bt cotton in India”, with Ajay Thutupalli Technological Forecasting and Social Change, 100, 198–212 (2015). (pdf)

2.              “Emergence of Controversy in Technology Transitions: Green Revolution and Bt cotton in India”, with Ajay Thutupalli Forthcoming in Technological Forecasting and Social Change.

3.              “The harnessing of biotechnology in India: Which roads to travel?” with S.Reid Technological Forecasting and Social Change.79 (4), 648–664, May 2012.(pdf)

4.              “Explaining divergence in catching-up in pharmaceuticals between India and Brazil using the NSI framework” with S. Guennif, Research Policy. 41, 430-441 (2012).(pdf)

5.              “Experimentation with strategy and evolution of dynamic capability in the Indian Pharmaceutical sector” with S.Athreye and D. Kale. Industrial and Corporate Change 18(4):729-759, (2009).( pdf )

6.              “La propriété intellectuelle : Un boulet pour les pays émergents”, Le Monde, (March 15, 2005).(pdf )

7.              “TRIPS and its possible impact on the biotech based segment of the Indian pharmaceutical industry”, with A. Maria, Economic and Political Weekly, Feb 12-18, 675-683,(Feb, 2005).(pdf)

8.              “Biotech in post TRIPS India” with P. Pradhan and M.Ravi, Nature Biotechnology, Volume 23, no.1, 18-19, (Jan, 2005).(pdf)

9.              “Who’s interested in biotechnology: R&D strategies, knowledge base and market sales of Indian biopharmaceutical firms” Research Policy vol. 31, 381-398 (2002).(pdf)

10.              “Rising to the technological challenge: Integration of biotechnology in the Indian Pharmaceutical Industry” with M.S. Venkataramani, International Journal of Biotechnology, vol 3, no. 1/2, 95-115, (2001). (pdf)

11.              “Resources, performance and strategy: a statistical examination of the integration of biotechnology in the Indian pharmaceutical sector”, with C. Putz, International Journal of Biotechnology, vol. 3, no.3/4, 374-390, (2001).(pdf)

12.              “Introduction to the special issue on biotechnology” International Journal of Biotechnology vol 3, no. 1/2, 1-3, (2001). (pdf)

13.              “The role of resources and incentives in the integration of biotechnology in developing countries : An Indian case study” with Visalakshi, International Journal of Biotechnology, vol. 2, no. 4, 297-312, (2001). (pdf)

14.              “Biotechnologies: l’Inde monte en puissance”, Biofutur, 174, (January 1998), 18-21. (pdf)

1.              "La rationalité des agents économiques va t-elle toujours à l’encontre de la coopération ? Le cas du jeu de la poule mouillée” with M.L. Cabon-Dhersin,  Revue d’Economie Politique (117 (2): 271-284, (Mar-Apr 2007)). (available on request)

2.              “Opportunism, trust and cooperation: A game theoretic approach with heterogeneous agents” with M.L. Cabon-Dhersin. Rationality and Society 19 (2): 203-228 (May 2007).(pdf)

3.              “Decision, irreversibility and flexibility : the irreversibility effect re-examined”, with A. Richard, Theory and Decision, 35, 259-276, (1993).(pdf)

4.              “Une approche élargie de l'effet irréversibilité”, with A. Richard et M. Trommetter,  Revue économique, no. 4, juillet, 769-784, (1992). (available on request)

1.              “Access to Critical Medicines: When are compulsory licenses effective in price negotiations?” with Eduardo Urias, Social Science & Medicine,135, 75-83 (2015).

2.              “Can Social Externalities Solve the Small Coalitions Puzzle in International Environmental Agreements?” with M.L. Cabon-Dhersin. Economics Bulletin, Vol 17, No. 4, 1-8. (2006). (pdf)

3.              “Les externalités sociales permettent-elles de résoudre la controverse théorique des « petites coalitions stables » dans les accords environnementaux ” with M.L. Cabon-Dhersin, Revue économique; 57(3): 431-38, (May,2006).(pdf)

4.              “Risk Aversion and the efficiency wage contract” with O. Chouikhi, Labour, 18 (1), 53-73. (2004).(pdf)

1.              “R&D Cooperation, Asymmetric Technological Capabilities and Rationale for Technology Parks” with V. Mukherjee, Theory and Decision. 71,  373-394. (2011).(pdf)

2.              “Does trust matter for R&D cooperation ? A game theoretic examination” with M.L. Cabon-Dhersin, Theory and Decision. 57, 143-180 (2004).(pdf)

3.              "An Analysis of vertical relationships between seed and biotech companies" with S.Lemarie , American Agricultural Economics Association Annual Meeting, Montreal, Canada, July 27-30 (2003).(pdf)

4.              “Partner selection and Contract Design in the Indian biotechnology sectors” with P.Audinet et M. ElAroui, The Developing Economies, vol. 39, no.1, 85-111, (2001).(pdf)

5.              “Technology cooperation between firms of developed and less-developed countries”, Economic Letters vol 68, 203-209, (2000). (pdf)

1.              “Bionetworks vs nanonetworks: A comparison of diffusion rates of emerging technologies” with Reid, S.E. and Niosi, J., International Journal of Biotechnology, Vol. 13, Nos. 1/2/3, 90-104,(2014). (pdf)

2.              "On estimating a knowledge production function at the firm and sectoral level using patent statistics" with M. El-Aroui and M. Carrere, Research Policy 37, 1568-1578 (2008).(pdf)

3.              “Decoding the information on genetic variation” with Roger Coronini, Marie-Angèle de Looze, Pierre Puget, and Gérard Bley. Nature BioTechnology, volume 21, no. 1, 21-29, (Jan 2003).(pdf)

4.              “Using patent statistics as competition indicators in the biotechnology sectors: An Application to France, Germany and the U.K.” with M.A. Delooze, Scientometrics, vol. 54, no. 3, 319-346, (2002).(pdf)

5.              “Biotechnology patents in the food sectors” with S.Malkoc, S.Murlis et K.van Wesemael, Nature BioTechnology, volume 19, no. 4, 383-384, (May, 2001). (pdf)

6.              “A note on using patent statistics to obtain competition indicators” with M.A. Delooze, Scientometrics, vol 49, no. 3, 547-551 (2000). (pdf)

7.              “Biotechnology patent applications in Europe” with M.A. De Looze, Nature BioTechnology, volume 17, number 1, 83-86, January (1999). (pdf)

1.              “Country specific characteristics of patent applications in France, Britain and Germany in the biotechnology sectors” with M.A. Delooze, Technology Analysis and Strategic Management, vol 14, no. 4, 457-480 (2002). (pdf)

2.              “Networks and Technological competence: An analysis of some NBFs in the biotechnology sectors in France and Britain” with J.Estades, Technology Analysis and Strategic Management, vol. 10, no.4, 483-495, (1998).(pdf)

3.              “Technology Creation in the Biotechnology Sectors: The French Connection” with D. Jolly, International Journal of Technology Management, Special Issue on Access to Technological and Financial Resources for SME innovation, vol 12, no. 7/8, 830-848, (1996).(pdf)

4.              “The French Evolution of Biotechnology”, Nature BioTechnology, vol 13, 757-759, (1995). (pdf)

5.              “Trajectories technologiques et mobilisation de réseaux dans des PME de biotechnologies en France et en Grande Bretagne”, with J.Estades, Revue Internationale PME**, vol. 10, no.3-4, 39-56, (1997). (pdf)

6.              “Creating Incentives: Lessons from the French experience”, Biotechnology and Development Monitor, No.26, 18-20, March (1996). (pdf)